Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Sun Pharma Advanced Research Company

BSE: 532872|NSE: SPARC|ISIN: INE232I01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 25, 16:00
358.15
2.4 (0.67%)
VOLUME 23,981
LIVE
NSE
May 25, 15:56
359.20
3.15 (0.88%)
VOLUME 159,831
Announcements on Sun Pharma Adv

8th-May-2018 18:52Source: BSE

Sun Pharma Advanced Research Company- Board Meeting-Outcome of Board Meeting

The Board of Directors of the Company at their meeting held from 04:45 pm to 06:45 pm today, inter alia, took on record and duly approved the Audited Financial Results for the quarter and year ended 3...

6th-Apr-2018 12:26Source: BSE

Sun Pharma Advanced Research Company- Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, For The Period Ended 31St March 2018

Pursuant to the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and elec...

23rd-Feb-2018 14:04Source: BSE

Sun Pharma Advanced Research Company- Announcement under Regulation 30 (LODR)-Updates

Pursuant to regulation 30 (1) of the SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015, we hereby inform you that the Company is receipt of a 'Demand Notice' under section 156 of th...

29th-Jan-2018 14:11Source: BSE

Sun Pharma Advanced Research Company- Outcome Of Board Meeting Dated 29Th January 2018

The Board of Directors of the Company at their meeting held from 12:00 Noon to 02:00 pm today, inter alia, took on record and duly approved the Un-audited financial results of the Company for the quar...

16th-Jan-2018 09:57Source: BSE

Sun Pharma Advanced Research Company- Shareholding for the Period Ended December 31, 2017

Sun Pharma Advanced Research Company Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly

15th-Jan-2018 16:38Source: BSE

Sun Pharma Advanced Research Company- Board Meeting On 29Th January 2018

Pursuant to regulation 29 (1) of the SEBI (Listing obligation & Disclosure Requirements) Regulation, 2015, we hereby inform you that a meeting of the Board of Directors of Sun Pharma Advanced Research...

10th-Jan-2018 12:36Source: BSE

Sun Pharma Advanced Research Company- Statement Of Investor Complaint For The Quarter Ended 31St December 2017

Pursuant to regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find below statement of Investor Complaints of the Company for the quarter ended 31s...

21st-Dec-2017 15:46Source: BSE

Sun Pharma Advanced Research Company- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Virtuous Finance Pvt Ltd

15th-Dec-2017 13:01Source: NSE

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding allotment of 4040404 securities pursuant to Conversion of Warrants at its meeting held on December 15, 2017

15th-Dec-2017 12:44Source: BSE

Sun Pharma Advanced Research Company- Allotment

This is to inform you that the Securities Allotment Committee of the Company, has in its meeting held from 12:00 Noon to 12:30 pm today, allotted 40,40,404 fully paid-up equity shares of face value o...

1 2 3 4 5 Next >>
Quick Links for Sun Pharma Advanced Research Company
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.